RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy

      한글로보기

      https://www.riss.kr/link?id=A105116485

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: This study sought to identify potential candidates for adjuvant radiotherapy and patterns of regional failure in patients who underwent curative-intent surgery for gallbladder cancer.
      Materials and Methods: Records for 70 patients with gallbladder cancer who underwent curative resection at a single institution between 2000 and 2016 were analysed retrospectively. No patients received adjuvant radiotherapy. Initial patterns of failure were evaluated. Regional recurrence was categorized according to the definitions of lymph node stations suggested by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
      Results: Median follow-up was 23 months. Locoregional recurrence as any component of first failure occurred in 29 patients (41.4%), with isolated locoregional recurrence in 13 (18.6%). Regional recurrence occurred in 23 patients, and 77 regional recurrences were identified. Commonly involved regional stations were #13, #12a2, #12p2, #12b2, #16a2, #16b1, #9, and #8.
      Independent prognostic factors for locoregional recurrence were ≥pT2 disease (hazard ratio [HR], 5.510; 95% confidence interval [CI], 1.260–24.094; p = 0.023) and R1 resection (HR, 6.981; 95% CI, 2.378–20.491; p < 0.001).
      Conclusion: Patients with pT2 disease or R1 resection after curative surgery for gallbladder cancer may benefit from adjuvant radiotherapy. Our findings on regional recurrence may help physicians construct a target volume for adjuvant radiotherapy.
      번역하기

      Purpose: This study sought to identify potential candidates for adjuvant radiotherapy and patterns of regional failure in patients who underwent curative-intent surgery for gallbladder cancer. Materials and Methods: Records for 70 patients with gallbl...

      Purpose: This study sought to identify potential candidates for adjuvant radiotherapy and patterns of regional failure in patients who underwent curative-intent surgery for gallbladder cancer.
      Materials and Methods: Records for 70 patients with gallbladder cancer who underwent curative resection at a single institution between 2000 and 2016 were analysed retrospectively. No patients received adjuvant radiotherapy. Initial patterns of failure were evaluated. Regional recurrence was categorized according to the definitions of lymph node stations suggested by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
      Results: Median follow-up was 23 months. Locoregional recurrence as any component of first failure occurred in 29 patients (41.4%), with isolated locoregional recurrence in 13 (18.6%). Regional recurrence occurred in 23 patients, and 77 regional recurrences were identified. Commonly involved regional stations were #13, #12a2, #12p2, #12b2, #16a2, #16b1, #9, and #8.
      Independent prognostic factors for locoregional recurrence were ≥pT2 disease (hazard ratio [HR], 5.510; 95% confidence interval [CI], 1.260–24.094; p = 0.023) and R1 resection (HR, 6.981; 95% CI, 2.378–20.491; p < 0.001).
      Conclusion: Patients with pT2 disease or R1 resection after curative surgery for gallbladder cancer may benefit from adjuvant radiotherapy. Our findings on regional recurrence may help physicians construct a target volume for adjuvant radiotherapy.

      더보기

      참고문헌 (Reference)

      1 배진숙, "The role of surgical clips in the evaluation of interfractional uncertainty for treatment of hepatobiliary and pancreatic cancer with postoperative radiotherapy" 대한방사선종양학회 35 (35): 65-70, 2017

      2 Sikora SS, "Surgical strategies in patients with gallbladder cancer: nihilism to optimism" 93 : 670-681, 2006

      3 Ben-Josef E, "SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma" 33 : 2617-2622, 2015

      4 Kim WS, "Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma" 14 : 679-687, 2010

      5 Margonis GA, "Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium" 18 : 872-878, 2016

      6 Abramson MA, "Radical resection for T1b gallbladder cancer: a decision analysis" 11 : 656-663, 2009

      7 Wang SJ, "Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer" 26 : 2112-2117, 2008

      8 이승은, "Practical Guidelines for the Surgical Treatment of Gallbladder Cancer" 대한의학회 29 (29): 1333-1340, 2014

      9 Jeong Y, "Postoperative radiotherapy for gallbladder cancer" 34 : 5621-5629, 2014

      10 김미영, "Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence" 대한방사선종양학회 34 (34): 297-304, 2016

      1 배진숙, "The role of surgical clips in the evaluation of interfractional uncertainty for treatment of hepatobiliary and pancreatic cancer with postoperative radiotherapy" 대한방사선종양학회 35 (35): 65-70, 2017

      2 Sikora SS, "Surgical strategies in patients with gallbladder cancer: nihilism to optimism" 93 : 670-681, 2006

      3 Ben-Josef E, "SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma" 33 : 2617-2622, 2015

      4 Kim WS, "Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma" 14 : 679-687, 2010

      5 Margonis GA, "Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium" 18 : 872-878, 2016

      6 Abramson MA, "Radical resection for T1b gallbladder cancer: a decision analysis" 11 : 656-663, 2009

      7 Wang SJ, "Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer" 26 : 2112-2117, 2008

      8 이승은, "Practical Guidelines for the Surgical Treatment of Gallbladder Cancer" 대한의학회 29 (29): 1333-1340, 2014

      9 Jeong Y, "Postoperative radiotherapy for gallbladder cancer" 34 : 5621-5629, 2014

      10 김미영, "Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence" 대한방사선종양학회 34 (34): 297-304, 2016

      11 Jarnagin WR, "Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies" 98 : 1689-1700, 2003

      12 Jung SJ, "Patterns of initial disease recurrence after resection of biliary tract cancer" 83 : 83-90, 2012

      13 Park HS, "Outcome of adjuvant therapy for gallbladder cancer" 79 : 168-173, 2010

      14 Glazer ES, "Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins" 16 : 1666-1671, 2012

      15 Itoh H, "Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder" 50 : 2231-2242, 2005

      16 Mitin T, "Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival" 109 : djw324-, 2017

      17 Miller G, "Gallbladder carcinoma" 34 : 306-312, 2008

      18 Hundal R, "Gallbladder cancer: epidemiology and outcome" 6 : 99-109, 2014

      19 Randi G, "Gallbladder cancer worldwide: geographical distribution and risk factors" 118 : 1591-1602, 2006

      20 Fong Y, "Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database" 243 : 767-774, 2006

      21 Williams TM, "Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer" 24 : 94-104, 2014

      22 Marinelli I, "Clinical target volume in biliary carcinoma: a systematic review of pathological studies" 37 : 955-961, 2017

      23 Miyazaki M, "Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition" 22 : 181-196, 2015

      24 Mantripragada KC, "Adjuvant therapy for resected gallbladder cancer: analysis of the National Cancer Data Base" 109 : djw202-, 2016

      25 Gold DG, "Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience" 75 : 150-155, 2009

      26 Mallick S, "Adjuvant radiotherapy in the treatment of gall bladder carcinoma: what is the current evidence" 28 : 1-6, 2016

      27 Sun XN, "Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy" 17 : 397-402, 2011

      28 Mojica P, "Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease" 96 : 8-13, 2007

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 선정 (해외등재 학술지 평가) KCI등재
      2020-12-01 평가 등재후보로 하락 (해외등재 학술지 평가) KCI등재후보
      2015-01-01 평가 SCOPUS 등재 (기타) KCI등재
      2013-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2012-04-01 평가 등재후보로 하락 (기타) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-12-30 학회명변경 영문명 : The Korean Society For Therapeutic Radiology And Oncology -> The Korean Society for Radiation Oncology KCI등재
      2011-08-22 학술지명변경 한글명 : 대한방사선종양학회지 -> Radiation oncology journal
      외국어명 : The Journal of the Korean Society for Therapeutic Radiology and Oncology -> Radiation oncology journal
      KCI등재
      2009-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.31 0.31 0.25
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.22 0.864 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼